We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 07, 2020

Stereotactic Ablative Radiotherapy Delays Progression and Recurrence in Selected Patients With Oligometastatic Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics


Additional Info

International Journal of Radiation Oncology*Biology*Physics
Patterns of Recurrence and Modes of Progression Following Metastasis Directed Therapy in Oligometastatic Castration Sensitive Prostate Cancer
Int. J. Radiat. Oncol. Biol. Phys 2020 Aug 13;[EPub Ahead of Print], MP Deek, K Taparra, D Dao, L Chan, R Phillips, RW Gao, ED Kwon, C Deville, DY Song, S Greco, MA Carducci, M Eisenberger, TL DeWeese, S Denmeade, K Pienta, CJ Paller, ES Antonarakis, KR Olivier, SS Park, BJ Stish, PT Tran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading